Astellas Pharma Inc.

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition Iveric_Bio_(2022)
OSI_Pharmaceuticals_(2010)
gptkbp:advertising gptkb:Mr._Taro_Suzuki
gptkb:Ms._Sayaka_Nishida
gptkb:Mr._Kenta_Yoshida
gptkb:Ms._Yuki_Tanaka
Mr._Hiroshi_Takeda
Mr._Shojiro_Matsumoto
Mr._Yujiro_Sakamoto
Ms._Akiko_Yamamoto
Ms._Natsuki_Kawai
Ms._Rika_Matsuda
gptkbp:awards gptkb:Top_Employer_Japan
Best_Workplaces_in_Japan
gptkbp:CEO gptkb:Kenji_Yasukawa
Ms._Akira_Sato
gptkbp:clinicalTrials conducts numerous clinical trials globally
invests in clinical research
gptkbp:competitors gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Merck_&_Co.
gptkb:Roche
Novartis
gptkbp:customerService Ms._Yoko_Fujimoto
Ms._Yumi_Takahashi
gptkbp:employeeCount around 17,000
gptkbp:founded 2005
gptkbp:global_presence over 70 countries
gptkbp:headCoach gptkb:Mr._Ryoichi_Nakamura
gptkbp:headquarters gptkb:Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label Astellas Pharma Inc.
gptkbp:industry pharmaceuticals
gptkbp:market global pharmaceutical market
gptkbp:operations gptkb:Ms._Aiko_Taniguchi
gptkbp:partnerships gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkbp:patentCitation holds numerous patents in pharmaceuticals
gptkbp:philanthropy community health programs
supports education initiatives
donates to health-related causes
gptkbp:products oncology drugs
immunosuppressants
urology drugs
gptkbp:regulates Mr._Tetsuya_Yamamoto
gptkbp:regulatoryCompliance Mr._Kenjiro_Saito
Mr._Takashi_Inoue
gptkbp:research gptkb:Dr._Masahiro_Kuroda
gptkbp:research_focus oncology
infectious diseases
transplantation
urology
gptkbp:revenue $12.5 billion (2022)
gptkbp:social_responsibility focus on sustainability
healthcare_access_initiatives
gptkbp:stockExchange 4503 (TSE)
gptkbp:subsidiary gptkb:Astellas_Pharma_US,_Inc.
gptkb:Astellas_Pharma_Europe_Ltd.
gptkbp:supplyChain gptkb:Mr._Hiroshi_Nakagawa
Ms._Haruka_Watanabe
gptkbp:tactics Mr. Masato Hoshino
gptkbp:website www.astellas.com